Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Psoriasis 2 ist eine autosomal dominante systemische autoinflammatorische Erkrankung mir vorwiegend kutaner Manifestation, die durch Mutationen im CARD14-Gen hervorgerufen wird.
| 1. |
Helms C et. al. (2003) A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. 
|
| 2. |
Nair RP et al. (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan.
|
| 3. |
Tomfohrde J et. al. (1994) Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q.
|
| 4. |
Hwu WL et. al. (2005) Mapping of psoriasis to 17q terminus.
|
| 5. |
Jordan CT et. al. (2012) PSORS2 is due to mutations in CARD14.
|
| 6. |
Jordan CT et al. (2012) Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
|
| 7. |
Nair RP et. al. () Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus.
|
| 8. |
Matthews D et. al. (1995) Confirmation of genetic heterogeneity in familial psoriasis.
|
| 9. |
Enlund F et al. (1999) Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families: confirmation of linkage to chromosome 6p (HLA region), and to 17q, but not to 4q.
|
| 10. |
Speckman RA et. al. (2003) Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility.
|
| 11. |
Capon F et. al. (2004) Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis.
|
| 12. |
Stuart P et. al. (2006) Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage.
|
| 13. |
Giardina E et. al. (2006) PSORS2 markers are not associated with psoriatic arthritis in the Italian population.
|
 |
Copyright © 2005-2024 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944 Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz | Impressum |
